Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vector - PubMed (original) (raw)

Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vector

I Joab et al. J Virol. 1987 Oct.

Abstract

The open reading frame which lies within the Epstein-Barr virus (EBV) T2 cDNA isolated by Bodescot et al. (M. Bodescot, O. Brison, and M. Perricaudet, Nucleic Acids Res. 14:2611-2620, 1986) was inserted into a eucaryotic expression vector containing a strong adenovirus promoter. The T2 cDNA contains viral genomic sequences from the short BLRF3 open reading frame fused to the adjacent BERF1 long open reading frame. After transfection of human cells, the recombinant plasmid directed the expression of a 140-kilodalton protein. The expressed protein had the same molecular weight, subcellular localization, and immunological characteristics as the EBV-determined nuclear antigen EBNA3, which is made in lymphocytes latently infected with EBV. Immunoprecipitation of extracts of transfected cells labeled with [32P]phosphoric acid showed that the EBNA3 protein is phosphorylated.

PubMed Disclaimer

Similar articles

• cDNA cloning and transient expression of the Epstein-Barr virus-determined nuclear antigen EBNA3B in human cells and identification of novel transcripts from its coding region.
  Kerdiles B, Walls D, Triki H, Perricaudet M, Joab I. Kerdiles B, et al. J Virol. 1990 Apr;64(4):1812-6. doi: 10.1128/JVI.64.4.1812-1816.1990. J Virol. 1990. PMID: 2157061 Free PMC article.
• A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes.
  Petti L, Sample J, Wang F, Kieff E. Petti L, et al. J Virol. 1988 Apr;62(4):1330-8. doi: 10.1128/JVI.62.4.1330-1338.1988. J Virol. 1988. PMID: 2831394 Free PMC article.
• Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family.
  Hennessy K, Wang F, Bushman EW, Kieff E. Hennessy K, et al. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5693-7. doi: 10.1073/pnas.83.15.5693. Proc Natl Acad Sci U S A. 1986. PMID: 3016714 Free PMC article.
• High-level expression of the Epstein-Barr virus EBNA1 protein in CV1 cells and human lymphoid cells using a SV40 late replacement vector.
  Hammarskjöld ML, Wang SC, Klein G. Hammarskjöld ML, et al. Gene. 1986;43(1-2):41-50. doi: 10.1016/0378-1119(86)90006-5. Gene. 1986. PMID: 3019836
• The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency.
  Styles CT, Paschos K, White RE, Farrell PJ. Styles CT, et al. Pathogens. 2018 Mar 17;7(1):31. doi: 10.3390/pathogens7010031. Pathogens. 2018. PMID: 29562595 Free PMC article. Review.

Cited by

• Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription.
  Radkov SA, Touitou R, Brehm A, Rowe M, West M, Kouzarides T, Allday MJ. Radkov SA, et al. J Virol. 1999 Jul;73(7):5688-97. doi: 10.1128/JVI.73.7.5688-5697.1999. J Virol. 1999. PMID: 10364319 Free PMC article.
• Mutational analysis of Epstein-Barr virus nuclear antigen 1 (EBNA 1).
  Polvino-Bodnar M, Kiso J, Schaffer PA. Polvino-Bodnar M, et al. Nucleic Acids Res. 1988 Apr 25;16(8):3415-35. doi: 10.1093/nar/16.8.3415. Nucleic Acids Res. 1988. PMID: 2836795 Free PMC article.
• Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.
  Radkov SA, Bain M, Farrell PJ, West M, Rowe M, Allday MJ. Radkov SA, et al. J Virol. 1997 Nov;71(11):8552-62. doi: 10.1128/JVI.71.11.8552-8562.1997. J Virol. 1997. PMID: 9343213 Free PMC article.
• The analysis of EBV proteins which are antigenic in vivo.
  Walls D, Perricaudet M, Gannon F. Walls D, et al. Nucleic Acids Res. 1988 Apr 11;16(7):2859-72. doi: 10.1093/nar/16.7.2859. Nucleic Acids Res. 1988. PMID: 2835748 Free PMC article.

References

1. 1. Virology. 1977 Mar;77(1):319-29 - PubMed
2. 1. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 - PubMed
3. 1. J Virol. 1980 Nov;36(2):506-18 - PubMed
4. 1. Anal Biochem. 1981 Apr;112(2):195-203 - PubMed
5. 1. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5688-92 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database